These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25830592)

  • 1. Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.
    Winterfeld U; Klinger G; Panchaud A; Stephens S; Arnon J; Malm H; Te Winkel B; Clementi M; Pistelli A; Maňáková E; Eleftheriou G; Merlob P; Kaplan YC; Buclin T; Rothuizen LE
    J Clin Psychopharmacol; 2015 Jun; 35(3):250-9. PubMed ID: 25830592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
    Djulus J; Koren G; Einarson TR; Wilton L; Shakir S; Diav-Citrin O; Kennedy D; Voyer Lavigne S; De Santis M; Einarson A
    J Clin Psychiatry; 2006 Aug; 67(8):1280-4. PubMed ID: 16965209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery outcome in relation to maternal use of some recently introduced antidepressants.
    Lennestål R; Källén B
    J Clin Psychopharmacol; 2007 Dec; 27(6):607-13. PubMed ID: 18004128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
    Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
    PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mirtazapine in pregnancy and lactation: data from a case series.
    Smit M; Wennink H; Heres M; Dolman KM; Honig A
    J Clin Psychopharmacol; 2015 Apr; 35(2):163-7. PubMed ID: 25689290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.
    Diav-Citrin O; Shechtman S; Ornoy S; Arnon J; Schaefer C; Garbis H; Clementi M; Ornoy A
    J Clin Psychiatry; 2005 Mar; 66(3):317-22. PubMed ID: 15766297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant drug exposure during pregnancy. CZTIS small prospective study.
    Manakova E; Hubickova L
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():53-6. PubMed ID: 22167208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.
    Kjaersgaard MI; Parner ET; Vestergaard M; Sørensen MJ; Olsen J; Christensen J; Bech BH; Pedersen LH
    PLoS One; 2013; 8(8):e72095. PubMed ID: 24015208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
    Gentile S
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1585-97. PubMed ID: 26135630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
    Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
    Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mirtazapine versus other antidepressive agents for depression].
    Knud Larsen J
    Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
    Kulin NA; Pastuszak A; Sage SR; Schick-Boschetto B; Spivey G; Feldkamp M; Ormond K; Matsui D; Stein-Schechman AK; Cook L; Brochu J; Rieder M; Koren G
    JAMA; 1998 Feb; 279(8):609-10. PubMed ID: 9486756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
    Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
    BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
    Louik C; Lin AE; Werler MM; Hernández-Díaz S; Mitchell AA
    N Engl J Med; 2007 Jun; 356(26):2675-83. PubMed ID: 17596601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A; Zhao JP; Sheehy O
    BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
    Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
    J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
    Diav-Citrin O; Shechtman S; Weinbaum D; Wajnberg R; Avgil M; Di Gianantonio E; Clementi M; Weber-Schoendorfer C; Schaefer C; Ornoy A
    Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
    Alwan S; Reefhuis J; Rasmussen SA; Olney RS; Friedman JM;
    N Engl J Med; 2007 Jun; 356(26):2684-92. PubMed ID: 17596602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.